Skip to main content

Table 2 Content of baseline and follow-up questionnaires

From: Efficacy of moxibustion for pre- or stage I hypertension: study protocol for a pilot randomized controlled trial

Measures Baseline End of treatment Follow-up
   at 4 weeks after randomization at 8, 12, 16, 20 and 24 weeks after randomization
Informed consent x - -
Inclusion/exclusion criteria x - -
Randomization x - -
Demographic information taking x - -
Blood pressure x x x
Blood test x x -
General assessment - x -
BMI (body mass index) x x x
NDI (neck disability index) x x x
EQ-5D (EuroQol) x x x
PSQI (Pittsburgh Sleep Quality Index) x x x
HRV (heart rate variability) x x x
Questionnaire of pattern identification x x x
SRI-MF (modified form of the Stress Response Inventory) x x x
FSS (Fatigue Severity Scale) x x x
Adverse events - x x